Hormonal Contraceptive Market by Method - Global Industry Analysis and Forecast to 2023

Published On : April 2018 Pages : 80 Category: Pharmaceuticals Report Code : HC04682

Industry Outlook and Trend Analysis

The Hormonal Contraceptive Market was worth USD 13.24 billion in 2014 and is expected to reach approximately USD 15.60 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 1.84% during the forecast period. Increasing awareness with respect to contraception techniques in rising countries, expanding investments by market players to create inventive devices, and strong government activities to enhance access are key patterns quickening market growth. Awareness programs by governments and market players enable boost the demand, and in this manner, market for contraceptives. The advent of long-acting reversible devices in the market is one of the significant driving variables.

Method Outlook and Trend Analysis

In 2016, contraceptive pills represented the biggest share of the market. It is evaluated to keep up its strength all through the estimate time frame. The development of the portion can be ascribed to simple and straightforward method of organization, easy accessibility of a wide range, high awareness about pills because of early market entry in comparison with long-acting devices, and high productivity of around 99% on convenient consumption.

Regional Outlook and Trend Analysis

North America commanded the worldwide hormonal prophylactic market in 2016. The locale is foreseen to hold its situation all through the gauge time frame. This can be credited to high per capita income, rising awareness about sexual health, strong presence of key market players, and substantial number of unintended pregnancies. Asia Pacific is anticipated to witness the speediest development amid the conjecture time frame. Advent of new female contraception devices, vast fertile population, rise in investment by leading players, and solid financial development are the central point supplementing the development of the area.

Competitive Insights

The major players in the market are Merck & Co, Pfizer, Bayer, Allergan, Teva Pharmaceutical Industries, Agile Therapeutics, Apothecus Inc. and Afaxys. Commercialization and approval of different products and growing geographical presence are real techniques implemented by industry members to improve their share of the overall industry.

The Hormonal Contraceptive Market is segmented as follows-

By Method:

  • Vaginal Ring
  • Pill
  • Injectable
  • Patch
  • Intrauterine Device (IUD)
  • Implant

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Hormonal Contraceptive Market, By Method, Estimates and Forecast, 2014-2023($Million)

·         Pill

·         Intrauterine Device (IUD)

·         Injectable

·         Vaginal Ring

·         Implant

·         Patch

·         Hormonal Contraceptive Market, By Region, Estimates and Forecast, 2014-2023($Million)

o    North America

§  North America Hormonal Contraceptive Market, By Country

o    U.S. Hormonal Contraceptive Market

o    Canada Hormonal Contraceptive Market

o    Mexico Hormonal Contraceptive Market

o    Europe

§  Europe Hormonal Contraceptive Market, By Country

o    Germany Hormonal Contraceptive Market

o    UK Hormonal Contraceptive Market

o    France Hormonal Contraceptive Market

o    Russia Hormonal Contraceptive Market

o    Italy Hormonal Contraceptive Market

o    Rest of Europe Hormonal Contraceptive Market

o    Asia-Pacific

§  Asia-Pacific Hormonal Contraceptive Market, By Country

o    China Hormonal Contraceptive Market

o    Japan Hormonal Contraceptive Market

o    South Korea Hormonal Contraceptive Market

o    India Hormonal Contraceptive Market

o    Southeast Asia Hormonal Contraceptive Market

o    Rest of Asia-Pacific Hormonal Contraceptive Market

o    South America

§  South America Hormonal Contraceptive Market

o    Brazil Hormonal Contraceptive Market

o    Argentina Hormonal Contraceptive Market

o    Columbia Hormonal Contraceptive Market

o    South Africa Hormonal Contraceptive Market

o    Rest of South America Hormonal Contraceptive Market

o    Middle East and Africa

§  Middle East and Africa Hormonal Contraceptive Market

o    Saudi Arabia Hormonal Contraceptive Market

o    UAE Hormonal Contraceptive Market

o    Egypt Hormonal Contraceptive Market

o    Nigeria Hormonal Contraceptive Market

o    South Africa Hormonal Contraceptive Market

o    Rest of MEA Hormonal Contraceptive Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Countries to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

5.       Hormonal Contraceptive Market, By Method

5.1.       Introduction

5.2.       Global Hormonal Contraceptive Sales, Revenue and Market Share by Method (2014-2018)

5.2.1.  Global Hormonal Contraceptive Sales and Sales Share by Method (2014-2018)

5.2.2.  Global Hormonal Contraceptive Revenue and Revenue Share by Method (2014-2018)

5.3.       Pill

5.3.1.  Global Pill Sales and Growth Rate (2014-2018)

5.4.       Intrauterine Device (IUD)

5.4.1.  Global Intrauterine Device (IUD) Sales and Growth Rate (2014-2018)

5.5.       Injectable

5.5.1.  Global Injectable Sales and Growth Rate (2014-2018)

5.6.       Vaginal Ring

5.6.1.  Global Vaginal Ring Sales and Growth Rate (2014-2018)

5.7.       Implant

5.7.1.  Global Implant Sales and Growth Rate (2014-2018)

5.8.       Patch

5.8.1.  Global Patch Sales and Growth Rate (2014-2018)

6.       Hormonal Contraceptive Market, By Region

6.1.       Introduction

6.2.       Global Hormonal Contraceptive Sales, Revenue and Market Share by Regions

6.2.1.  Global Hormonal Contraceptive Sales by Regions (2014-2018)

6.2.2.  Global Hormonal Contraceptive Revenue by Regions (2014-2018)

6.3.       North America Hormonal Contraceptive by Countries

6.3.1.  North America Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.3.2.  North America Hormonal Contraceptive Revenue and Growth Rate (2014-2018)

6.3.3.  North America Hormonal Contraceptive Sales by Countries (2014-2018)

6.3.4.  North America Hormonal Contraceptive Revenue (Million USD) by Countries (2014-2018)

6.3.5.  U.S.

6.3.5.1.    United States Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.3.5.2.    United States Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.3.6.  Canada

6.3.6.1.    Canada Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.3.6.2.    Canada Hormonal Contraceptive Sales (Millions USD) and Growth Rate (2014-2018)

6.3.7.  Mexico

6.3.7.1.    Mexico Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.3.7.2.    Mexico Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.       Europe Hormonal Contraceptive by Countries

6.4.1.  Europe Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.4.2.  Europe Hormonal Contraceptive Revenue and Growth Rate (2014-2018)

6.4.3.  Europe Hormonal Contraceptive Sales by Countries (2014-2018)

6.4.4.  Europe Hormonal Contraceptive Revenue (Million USD) by Countries (2014-2018)

6.4.5.  Germany

6.4.5.1.    Germany Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.4.5.2.    Germany Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.6.  UK

6.4.6.1.    UK Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.4.6.2.    UK Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.7.  France

6.4.7.1.    France Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.4.7.2.    France Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.8.  Russia

6.4.8.1.    Russia Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.4.8.2.    Russia Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.9.  Italy

6.4.9.1.    Italy Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.4.9.2.    Italy Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.10.      Rest of Europe

6.4.10.1. Rest of Europe Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.4.10.2. Rest of Europe Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.       Asia-Pacific

6.5.1.  Asia-Pacific Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.5.2.  Asia-Pacific Hormonal Contraceptive Revenue and Growth Rate (2014-2018)

6.5.3.  Asia-Pacific Hormonal Contraceptive Sales by Countries (2014-2018)

6.5.4.  Asia-Pacific Hormonal Contraceptive Revenue (Million USD) by Countries (2014-2018)

6.5.5.  China

6.5.5.1.    China Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.5.5.2.    China Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.6.  Japan

6.5.6.1.    Japan Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.5.6.2.    Japan Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.6.3.     

6.5.7.  Korea

6.5.7.1.    Korea Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.5.7.2.    Korea Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.8.  India

6.5.8.1.    India Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.5.8.2.    India Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.9.  Southeast Asia

6.5.9.1.    Southeast Asia Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.5.9.2.    Southeast Asia Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.10.      Rest of Asia-Pacific

6.5.10.1. Rest of Asia-Pacific Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.5.10.2. Rest of Asia-Pacific Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.       South America

6.6.1.  South America Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.6.2.  South America Hormonal Contraceptive Revenue and Growth Rate (2014-2018)

6.6.3.  South America Hormonal Contraceptive Sales by Countries (2014-2018)

6.6.4.  South America Hormonal Contraceptive Revenue (Million USD) by Countries (2014-2018)

6.6.5.  Brazil

6.6.5.1.    Brazil Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.6.5.2.    Brazil Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.6.  Argentina

6.6.6.1.    Argentina Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.6.6.2.    Argentina Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.7.  Columbia

6.6.7.1.    Columbia Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.6.7.2.    Columbia Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.8.  Rest of South America

6.6.8.1.    Rest of South America Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.6.8.2.    Rest of South America Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.       Middle East and Africa

6.7.1.  Middle East and Africa Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.7.2.  Middle East and Africa Hormonal Contraceptive Revenue and Growth Rate (2014-2018)

6.7.3.  Middle East and Africa Hormonal Contraceptive Sales by Countries (2014-2018)

6.7.4.  Middle East and Africa Hormonal Contraceptive Revenue (Million USD) by Countries (2014-2018)

6.7.5.  Saudi Arabia

6.7.5.1.    Saudi Arabia Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.7.5.2.    Saudi Arabia Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.6.  United Arab Emirates

6.7.6.1.    United Arab Emirates Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.7.6.2.    United Arab Emirates Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.7.  Egypt

6.7.7.1.    Egypt Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.7.7.2.    Egypt Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.8.  Nigeria

6.7.8.1.    Nigeria Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.7.8.2.    Nigeria Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.9.  South Africa

6.7.9.1.    South Africa Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.7.9.2.    South Africa Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.10.      Rest of Middle East and Africa

6.7.10.1. Rest of Middle East and Africa Hormonal Contraceptive Sales and Growth Rate (2014-2018)

6.7.10.2. Rest of Middle East and Africa Hormonal Contraceptive Revenue (Millions USD) and Growth Rate (2014-2018)

7.       Company Profiles

7.1.         Allergan

7.1.1.  Business Overview

7.1.2.  Product Portfolio

7.1.3.  Strategic Developments

7.1.4.  Sales, Revenue and Market Share

7.2.       Bayer AG

7.2.1.  Business Overview

7.2.2.  Product Portfolio

7.2.3.  Strategic Developments

7.2.4.  Sales, Revenue and Market Share

7.3.       Merck & Co., Inc.

7.3.1.  Business Overview

7.3.2.  Product Portfolio

7.3.3.  Strategic Developments

7.3.4.  Sales, Revenue and Market Share

7.4.       Pfizer

7.4.1.  Business Overview

7.4.2.  Product Portfolio

7.4.3.  Strategic Developments

7.4.4.  Sales, Revenue and Market Share

7.5.       Afaxys, Inc.

7.5.1.  Business Overview

7.5.2.  Product Portfolio

7.5.3.  Strategic Developments

7.5.4.  Sales, Revenue and Market Share

7.6.       Teva Pharmaceutical Industries Ltd

7.6.1.  Business Overview

7.6.2.  Product Portfolio

7.6.3.  Strategic Developments

7.6.4.  Sales, Revenue and Market Share

7.7.        Agile Therapeutics

7.7.1.  Business Overview

7.7.2.  Product Portfolio

7.7.3.  Strategic Developments

7.7.4.  Sales, Revenue and Market Share

7.8.       Apothecus Pharmaceutical Corp.

7.8.1.  Business Overview

7.8.2.  Product Portfolio

7.8.3.  Strategic Developments

7.8.4.  Sales, Revenue and Market Share

8.       Global Hormonal Contraceptive Market Competition, by Manufacturer

8.1.       Global Hormonal Contraceptive Sales and Market Share by Manufacturer (2016-2017)

8.2.       Global Hormonal Contraceptive Revenue and Market Share by Manufacturer (2016-2017)

8.3.       Global Hormonal Contraceptive Price by Manufacturer (2016-2017)

8.4.       Top 5 Hormonal Contraceptive Manufacturer Market Share

8.5.       Market Competition Trend

9.       Hormonal Contraceptive Market Forecast (2018-2023)

9.1.       Global Hormonal Contraceptive Sales, Revenue (Millions USD) and Growth Rate (2018-2023)

9.2.       Hormonal Contraceptive Market Forecast by Regions (2018-2023)

9.2.1.  North America Hormonal Contraceptive Market Forecast (2018-2023)

9.2.1.1.    United States Hormonal Contraceptive Market Forecast (2018-2023)

9.2.1.2.    Canada Hormonal Contraceptive Market Forecast (2018-2023)

9.2.1.3.    Mexico Hormonal Contraceptive Market Forecast (2018-2023)

9.2.2.  Europe Hormonal Contraceptive Market Forecast (2018-2023)

9.2.2.1.    Germany Hormonal Contraceptive Market Forecast (2018-2023)

9.2.2.2.    United Kingdom Hormonal Contraceptives Market Forecast (2018-2023)

9.2.2.3.    France Hormonal Contraceptive Market Forecast (2018-2023)

9.2.2.4.    Russia Hormonal Contraceptive Market Forecast (2018-2023)

9.2.2.5.    Italy Hormonal Contraceptive Market Forecast (2018-2023)

9.2.2.6.    Rest of the Europe Hormonal Contraceptive Market Forecast (2018-2023)

9.2.3.  Asia-Pacific Hormonal Contraceptive Market Forecast (2018-2023)

9.2.3.1.    China Hormonal Contraceptive Market Forecast (2018-2023)

9.2.3.2.    Japan Hormonal Contraceptive Market Forecast (2018-2023)

9.2.3.3.    Korea Hormonal Contraceptive Market Forecast (2018-2023)

9.2.3.4.    India Hormonal Contraceptive Market Forecast (2018-2023)

9.2.3.5.    Southeast Asia Hormonal Contraceptive Market Forecast (2018-2023)

9.2.3.6.    Rest of Asia-Pacific Hormonal Contraceptive Market Forecast (2018-2023)

9.2.4.  South America Hormonal Contraceptive Market Forecast (2018-2023)

9.2.4.1.    Brazil Hormonal Contraceptive Market Forecast (2018-2023)

9.2.4.2.    Argentina Hormonal Contraceptive Market Forecast (2018-2023)

9.2.4.3.    Columbia Hormonal Contraceptive Market Forecast (2018-2023)

9.2.4.4.    Rest of South America Hormonal Contraceptive Market Forecast (2018-2023)

9.2.5.  Middle East and Africa Hormonal Contraceptive Market Forecast (2018-2023)

9.2.5.1.    Saudi Arabia Hormonal Contraceptive Market Forecast (2018-2023)

9.2.5.2.    UAE Hormonal Contraceptive Market Forecast (2018-2023)

9.2.5.3.    Egypt Hormonal Contraceptive Market Forecast (2018-2023)

9.2.5.4.    Nigeria Hormonal Contraceptive Market Forecast (2018-2023)

9.2.5.5.    South Africa Hormonal Contraceptive Market Forecast (2018-2023)

9.2.5.6.    Rest of MEA Hormonal Contraceptive Market Forecast (2018-2023)

9.3.       Hormonal Contraceptive Market Forecast by Method (2018-2023)

9.3.1.  Global Hormonal Contraceptive Sales Forecast by Method (2018-2023)

9.3.2.  Global Hormonal Contraceptive Sales Market Share Forecast by Method (2018-2023)

 


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Hormonal Contraceptive Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*